Cargando…
E-type prostanoid receptor 4 (EP4) in disease and therapy
The large variety of biological functions governed by prostaglandin (PG) E(2) is mediated by signaling through four distinct E-type prostanoid (EP) receptors. The availability of mouse strains with genetic ablation of each EP receptor subtype and the development of selective EP agonists and antagoni...
Autores principales: | Konya, Viktoria, Marsche, Gunther, Schuligoi, Rufina, Heinemann, Akos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661976/ https://www.ncbi.nlm.nih.gov/pubmed/23523686 http://dx.doi.org/10.1016/j.pharmthera.2013.03.006 |
Ejemplares similares
-
Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation
por: Philipose, Sonia, et al.
Publicado: (2012) -
Laropiprant attenuates EP(3) and TP prostanoid receptor-mediated thrombus formation
por: Philipose, Sonia, et al.
Publicado: (2012) -
The role of PGE(2) EP(4) receptors in the regulation of endothelial barrier function
por: Kampitsch, Nora, et al.
Publicado: (2012) -
Inhibitory effects of prostaglandin EP(4 )receptors on human eosinophils
por: Luschnig-Schratl, Petra, et al.
Publicado: (2009) -
A biological target for antiplatelet therapy: the prostaglandin E(2) receptor EP(4)
por: Philipose, Sonia, et al.
Publicado: (2010)